Risk classification for overall survival by the neutrophil–lymphocyte ratio and the number of metastatic sites in patients treated with pembrolizumab—a multicenter collaborative study in Japan

Taizo Uchimoto, Kazumasa Komura, Wataru Fukuokaya, Takahiro Kimura, Kazuhiro Takahashi, Yusuke Yano, Kazuki Nishimura, Keita Nakamori, Yuya Fujiwara, Tomohisa Matsunaga, Takeshi Tsutsumi, Takuya Tsujino, Ryoichi Maenosono, Yuki Yoshikawa, Kohei Taniguchi, Tomohito Tanaka, Hirofumi Uehara, Hajime Hirano, Hayahito Nomi, Kiyoshi TakaharaTeruo Inamoto, Shin Egawa, Haruhito Azuma

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk classification for overall survival by the neutrophil–lymphocyte ratio and the number of metastatic sites in patients treated with pembrolizumab—a multicenter collaborative study in Japan'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience